Group One Trading
OLMA icon

Group One Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Group One Trading’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.6K Sell
7,400
-38,000
-84% -$509K ﹤0.01% 4924
2026
Q1 		$677K Sell
45,400
-75,100
-62% -$1.67M ﹤0.01% 3055
2025
Q4 		$3.01M Buy
120,500
+16,000
+15% +$285K 0.01% 1919
2025
Q3 		$1.02M Buy
104,500
+104,400
+104,400% +$627K ﹤0.01% 3009
2025
Q2 		$426 Buy
+100
New +$446 ﹤0.01% 7680
2025
Q1 		– Sell
-15,400
Closed -$89.8K – 8140
2024
Q4 		$89.8K Sell
15,400
-76,600
-83% -$765K ﹤0.01% 4614
2024
Q3 		$1.1M Buy
92,000
+9,500
+12% +$121K ﹤0.01% 2216
2024
Q2 		$893K Buy
82,500
+81,700
+10,213% +$886K ﹤0.01% 2080
2024
Q1 		$9.06K Sell
800
-18,100
-96% -$234K ﹤0.01% 5920
2023
Q4 		$265K Buy
18,900
+12,900
+215% +$173K ﹤0.01% 3609
2023
Q3 		$74.1K Buy
6,000
+5,100
+567% +$52K ﹤0.01% 4734
2023
Q2 		$8.13K Buy
+900
New +$5.43K ﹤0.01% 6494
2022
Q4 		– Sell
-5,200
Closed -$14K – 7848
2022
Q3 		$14K Buy
5,200
+5,000
+2,500% +$21.2K ﹤0.01% 6301
2022
Q2 		$1K Buy
+200
New +$634 ﹤0.01% 7593

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Group One Trading's OLMA Position: Q2 2026 in Review

Group One Trading reduced its Olema Pharmaceuticals (OLMA) stake by 39% in Q2 2026, selling an estimated $193K and leaving 22,746 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3994.

Group One Trading first reported a position in OLMA in Q4 2021 and has held it in 8 quarters since. The position peaked at $554K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Group One Trading held 22,746 shares of Olema Pharmaceuticals worth $285K as of Q2 2026.
  • Group One Trading sold 14,434 Olema Pharmaceuticals shares in Q2 2026, an estimated $193K.
  • Olema Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3994 holding.
  • Group One Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
  • Group One Trading's Olema Pharmaceuticals position peaked at $554K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.